T1	disease_or_phenotypic_feature 53 59	cancer
T2	chemical 80 90	biological
T3	chemical 151 155	drug
T4	chemical 186 191	Fatty
T5	chemical 186 197	Fatty acids
T6	disease_or_phenotypic_feature 211 220	sensitive
T7	chemical 320 332	α-tocopherol
T8	chemical 333 344	(vitamin E)
T9	chemical 356 363	vitamin
T10	chemical 454 457	fat
T11	chemical 470 482	α-tocopherol
T12	disease_or_phenotypic_feature 497 515	obesity-associated
T13	chemical 591 604	α-tocopherols
T14	chemical 614 630	d6-α-tocopherols
T15	disease_or_phenotypic_feature 768 785	hospital-acquired
T16	disease_or_phenotypic_feature 786 797	anaphylaxis
T17	chemical 826 840	cephalosporins
T18	chemical 918 929	Sulfonamide
T19	missed_chemical 918 938;963 991	Sulfonamide moieties present in several compounds
T20	disease_or_phenotypic_feature 1031 1039	diseases
T21	corrected_disease_or_phenotypic_feature 1063 1080	tropical diseases
T22	disease_or_phenotypic_feature 1072 1080	diseases
T23	disease_or_phenotypic_feature 1415 1423	cataract
T24	chemical 1445 1454	oxidative
T25	disease_or_phenotypic_feature 1522 1528	cancer
T26	chemical 1529 1544	antigen-binding
T27	chemical 1552 1570	anti-α-galactoside
T28	chemical 1625 1637	lipoprotein(
T29	chemical 1658 1667	Isoniazid
T30	disease_or_phenotypic_feature 1714 1726	tuberculosis
T31	chemical 1772 1776	zinc
T32	disease_or_phenotypic_feature 1872 1887	adenocarcinomas
T33	chemical 1927 1932	group
T34	chemical 1962 1978	serine/threonine
T35	chemical 1979 1986	protein
T36	chemical 2034 2042	proteins
T37	disease_or_phenotypic_feature 2091 2096	blood
T38	disease_or_phenotypic_feature 2141 2173	dystrophic epidermolysis bullosa
T39	disease_or_phenotypic_feature 2216 2224	disorder
T40	chemical 2288 2296	collagen
T41	chemical 2437 2444	glucose
T42	disease_or_phenotypic_feature 2483 2494	prediabetes
T43	disease_or_phenotypic_feature 2668 2671	STS
T44	chemical 2789 2794	group
T45	disease_or_phenotypic_feature 2832 2835	STS
T46	chemical 2918 2926	fluoride
T47	disease_or_phenotypic_feature 2927 2938	sensitivity
T48	chemical 3004 3010	saline
T49	disease_or_phenotypic_feature 3157 3178	pulmonary sarcoidosis
T50	chemical 3279 3293	phosphorylated
T51	disease_or_phenotypic_feature 3294 3315	ataxia telangiectasia
T52	disease_or_phenotypic_feature 3342 3363	ataxia telangiectasia
T53	disease_or_phenotypic_feature 3368 3380	Rad3-related
T54	chemical 3388 3395	protein
T55	disease_or_phenotypic_feature 3554 3581	primary hyperparathyroidism
T56	chemical 3663 3670	thyroid
T57	chemical 3847 3860	messenger RNA
T58	disease_or_phenotypic_feature 3882 3885	ABC
T59	disease_or_phenotypic_feature 4157 4160	CRC
T60	chemical 4209 4219	biomarkers
T61	disease_or_phenotypic_feature 4224 4227	CRC
T62	disease_or_phenotypic_feature 4274 4277	PCA
T63	chemical 4388 4393	water
R2	treats Arg1:T29 Arg2:T30
R3	treats Arg1:T19 Arg2:T22
R4	treats Arg1:T19 Arg2:T20
R5	treats Arg1:T19 Arg2:T21
R6	treats Arg1:T3 Arg2:T1
T64	missed_chemical 1669 1672	INH
R7	treats Arg1:T64 Arg2:T30	
T65	missed_chemical 1845 1855	chemically
T66	missed_disease_or_phenotypic_feature 1864 1887	mammary adenocarcinomas
R8	causes_or_contributes_to Arg1:T65 Arg2:T66	
T67	corrected_disease_or_phenotypic_feature 768 797	hospital-acquired anaphylaxis
R10	causes_or_contributes_to Arg1:T17 Arg2:T67	
R1	causes_or_contributes_to Arg1:T31 Arg2:T66	
R9	causes_or_contributes_to Arg1:T46 Arg2:T47	
T68	corrected_disease_or_phenotypic_feature 497 532	obesity-associated hepato-steatosis
